Pembrolizumab belongs to a class of medications known as immunotherapy. It works with your body's immune system to fight against the tumour cells.
Other possible side effects (usually mild, may occur within a few weeks after 1st dose)
Please seek medical attention if any of the following occurs:
Subscribe to our mailing list to get the updates to your email inbox...
SHP-Head Office, 167 Jalan Bukit Merah Connection One (Tower 5), #15-10, Singapore 150167